Samsara Vision’s SING IMT: Game Changer for the Advanced AMD Patient

In this episode, I discuss Samsara Vision's SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD.

Brought to you by Alcon

·       Welcome to another exciting episode of Eye Care insider :14

·       Intro for Rebecca Kammer, OD, PhD :27

·       Dr. Kammer's background 1:28

·       Defining late-stage AMD patients and treatments available 5:11

·       The SING IMT 9:46

·       US Concerto Study Website – to learn more about the study 13:13

·       Visual acuity and the SING IMT 13:48

·       US trial, recruitment and patient eligibility 17:18

·       Contact toll-free 1-866-393-3767 discuss eligibility, participation and questions 20:39

·       SING IMT as an option for patients 22:55

·       Thanks for listening 27:30

We'd love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. You can reach Dr. Kammer at rkammer@samsaravision.com.

Rebecca Kammer, OD, PhD, is the vice president of worldwide clinical and medical affairs for Samsara Vision, Inc., an adjunct professor at University of California, Irvine and a diplomate in low vision of the American Academy of Optometry.

Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI. Kammer reports being a clinical advisor to Biovisics and Eyedaptic.